PRECORDIOR

Our solution: The digital cardiac biomarkers we are developing for several major heart diseases can replace invasive and costly standard care technologies, enabling faster care and with lower cost... We are a health technology company based in Finland and the United States. Originally an academic spinoff, we have over a decade of research and algorithm development as basis... Today, our patented technology enables a digital cardiac biomarker for several major heart disease, representing a disruption in battling heart disease, the costliest and deadliest disease in the world.

Also known as: Precordior Ltd.

Primary location: Turku Finland